Madison Avenue Partners’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433K | Sell |
1,311,362
-1,154,261
| -47% | -$381K | 0.03% | 26 |
|
|
2025
Q1 | $769K | Sell |
2,465,623
-1,257,004
| -34% | -$392K | 0.07% | 19 |
|
|
2024
Q4 | $3.48M | Sell |
3,722,627
-394,146
| -10% | -$368K | 0.37% | 13 |
|
|
2024
Q3 | $4.86M | Buy |
4,116,773
+34,673
| +0.8% | +$40.9K | 0.45% | 19 |
|
|
2024
Q2 | $3.14M | Buy |
4,082,100
+433,591
| +12% | +$334K | 0.4% | 18 |
|
|
2024
Q1 | $11.1M | Hold |
3,648,509
| – | – | 1.8% | 11 |
|
|
2023
Q4 | $11.7M | Hold |
3,648,509
| – | – | 1.66% | 11 |
|
|
2023
Q3 | $14M | Buy |
3,648,509
+340,904
| +10% | +$1.31M | 1.99% | 9 |
|
|
2023
Q2 | $10.8M | Buy |
3,307,605
+203,002
| +7% | +$666K | 2.37% | 10 |
|
|
2023
Q1 | $8.01M | Buy |
3,104,603
+383,552
| +14% | +$990K | 1.72% | 11 |
|
|
2022
Q4 | $5.06M | Buy |
2,721,051
+1,327,029
| +95% | +$2.47M | 0.9% | 16 |
|
|
2022
Q3 | $2.57M | Buy |
+1,394,022
| New | +$2.57M | 0.55% | 15 |
|